This is an electronic version of an article published in Homeopathy, 94 (3), pp. 153-163, July 2005. The definitive version in Homeopathy is available online at: Abstract Objective To systematically review the research evidence on the effectiveness of homeopathy for the treatment of depression and depressive disorders Methods A comprehensive search of major biomedical databases including MEDLINE, EMBASE, ClNAHL, PsycINFO and the Cochrane Library was conducted. Specialist complementary and alternative medicine (CAM) databases including AMED, CISCOM and Hom-Inform were also searched. Additionally, efforts were made to identify unpublished and ongoing research using relevant sources and experts in the field. Relevant research was categorised by study type and appraised according to study design. Clinical commentaries were obtained for studies reporting clinical outcomes.
Introduction
Mental health problems such as anxiety, depression and insomnia are among the most common reasons for individuals to seek treatment with complementary therapies in the US. 1 This survey revealed that prevalence of the use of complementary and alternative medicine for the United States in 1997 was 42 per cent with chronic conditions, including depression and anxiety, comprising the conditions for which therapies were most frequently sought: 40.9% of adults with depression and 42.7% of adults with anxiety had used complementary therapies in the previous year. 1 Several surveys have focussed on the use of complementary and alternative medicine by patients with psychiatric disorders. Davidson and colleagues conducted a study to determine the frequency of psychiatric disorders in patients receiving complementary medical care in the UK and the USA. 2 Psychiatric disorders were relatively frequent among these patients. 74% of the British patients and 60.6% of the American patients had a lifetime psychiatric diagnosis. Major depression (52% of UK patients and 33.3% of USA patients) and any anxiety disorders were the commonest lifetime diagnoses. 46% of the UK patients and 30.3% of the USA patients had a current psychiatric diagnosis. Six per cent of the total currently suffered from a major depression and 25.3% of the total met the criteria for at least one anxiety disorder. A high rate of use of complementary therapies in adults who met criteria for common psychiatric disorders was also reported by Unutzer and colleagues. 3 Respondents who met the criteria for major depression and panic disorder were particularly likely to report use. Finally, a recent, large, prospective study of 3981 patients consulting classical homeopaths in Germany demonstrated a similar situation with depression among the 10 most frequent diagnoses encountered. 4 Depression Depression refers to a wide range of mental health problems characterised by the absence of a positive affect, low mood and a range of associated emotional, cognitive, physical and behavioural symptoms. Behavioural and physical symptoms typically include tearfulness, irritability, social withdrawal, reduced sleep, exacerbation of pre-existing pain and pain secondary to increased muscle tension and other causes, poor appetite, lack of libido, fatigue and diminished activity, although agitation is also common and marked anxiety frequent. Along with a loss of interest and enjoyment in everyday life, feelings of guilt, worthlessness and deserved punishment are common, as are lowered self-esteem, loss of confidence, feelings of helplessness, suicidal ideation and attempts at self-harm or suicide. Cognitive changes include poor concentration and reduced attention, pessimistic and recurrently negative thoughts about oneself, one's past and the future, mental slowing and rumination.
Depression is the most common mental disorder in community settings, and is a major cause of disability across the world. In 1990, it was the fourth commonest cause of loss of disability adjusted life years in the world, and by 2020, it is projected to become the second commonest cause. 5 The estimated point prevalence for major depression among 16 to 65 year olds in the UK is 21/1000. If the broader category of "mixed depression and anxiety" is included, this rises to 98/1000. Apart from the subjective suffering experienced by people who are depressed, the impact on social and occupational functioning, physical health and mortality is substantial. The impact on physical health sets depression alongside all the major chronic and disabling physical illnesses such as diabetes, arthritis and hypertension. 6 A range of therapeutic approaches are available, the most widely used, in developed countries, is antidepressant drugs. 7 However these are associated with a number of problems including poor compliance and toxicity in overdose (particularly with the older tricyclic drugs) while the more modern selective serotonin uptake reinhibitor (SSRI) drugs are associated with increased incidence of self harm in young people and of suicide 8, 9 . Patients may turn to complementary therapies due to side effects of medication, time and effort associated with non-pharmacological therapies, lack of response or simply preference for the complementary approach.
Homeopathy
Homeopathy is among the most popular of CAM therapies and is widely used in western European countries including France, Germany, the Netherlands and the UK. It is also popular elsewhere in the world, notably the Indian subcontinent and Latin America and there has been rapid recent growth of usage in the USA 1 . Its perceived safety is an important factor motivating patients to use homeopathy. 10 The extensive use of homeopathy, together with interest in homeopathy as a treatment for depression 11, 12, 13 suggested that a review of the evidence for effectiveness in this condition would be valuable.
Aim and objectives
The aim of this study was to evaluate the evidence from a range of sources on the effectiveness (and safety and patient satisfaction) of homoeopathy for the treatment of depression.
Methods

Summary of search strategy
A comprehensive search for clinical research was carried out. Systematic searches were conducted on a range of databases, citations were sought from relevant reviews and several websites were also included in the search, including those of MIND and the Mental Health Foundation. 
Databases searched
Search terms
The basic search terms for homeopathy included: 
Filtering
Relevant research was categorised by study type according to a flow-chart system developed for this project. The basic categories used are shown in Table 1 . Animal research and basic lab-based research were not included in the categorisation process.
Selection criteria
Types of study
• Initially only controlled studies were selected (randomised and non-randomised).
As very few were located, other studies such as uncontrolled and observational studies were also included. Attempts were also made to locate relevant qualitative studies.
• No language restrictions were imposed at the search and filtering stage and translations were obtained for any potentially relevant studies in languages other than English. Data extraction and appraisal were conducted independently by two researchers (KP, GK) for each study and any disagreements or discrepancies were resolved by discussion.
Types of participants
Where consensus could not be obtained, a third reviewer (JR) was available for consultation.
Clinical commentaries
Clinicians with training and experience in psychiatry and homeopathy and clinical research in these area (HR, PF) commented on studies focusing on clinical relevance and practical issues. Commentary frameworks were specifically developed for this project, these incorporate a number of closed and open questions with space for further comments. Summaries of these commentaries are provided in the tables of studies.
Main results
Types of study and numbers identified (Figure 1)
Systematic reviews:
• No systematic reviews specifically on the topic of homeopathy for depression were identified. One systematic review 15 • 1 RCT (depression associated with chronic fatigue syndrome) 18, 19 was located Other studies located:
• 4 UCT/case series 20, 21, 22, 23, 24 • 1 observational survey-based study 25 • 1 multivariate analysis 26 • Over 50 single case reports/studies • A number of surveys and patient outcome studies No relevant qualitative research studies were located
Language of studies located
Only one study in a language other than English was located 16 . A translation was obtained.
The Evidence
Based on conventional measures of quality and accepted study types, i.e. adequately randomised and controlled studies of sufficient power, no relevant studies were located.
Those that were located were of low methodological quality, had insufficient numbers of participants or were uncontrolled. However, all located studies are presented in the tables together with comments on their methodology and clinical relevance in an attempt to highlight the issues to be addressed in future research in this area.
Summary of each study
Only one published randomised controlled trial examining the use of homeopathy for depression was located. This trial 16 , conducted in France, has been described previously
as an 'open randomised study' 27 comparing homeopathic treatment with diazepam in patients with mixed anxiety and depressive states. Positive results for an homeopathic complex, a standardised proprietary formula, were reported. In the criteria-based systematic review of Kleijnen and colleagues 15 the trial scored only 45 out of 100 for methodological rigour, the cut off point for better studies was ≥55. The use of an anxiolytic drug as a control appears inappropriate in a trial in patients with depression and further appraisal of the study revealed a lack of information on many of the measures of trial quality; the method of randomisation, whether assessors were blinded, compliance and co-interventions. There were also problems in the diagnostic classification and inappropriate outcome measures were used. In subsequent meta-analyses and reviews, no further controlled trials specific to homeopathy and depression are cited. 28, 29, 30, 31, 32 Studies conducted by the Homoeopathic Medicine Research Group, as a report to the European Commission, also failed to uncover any new controlled trials. 33, 34 A randomised controlled trial of homeopathy for depression in primary care was, however, conducted in 1999 at an East London group practice in collaboration with the Royal London Homeopathic hospital. 17 The aim of this pilot study was to assess the feasibility of a general practice based trial comparing the effectiveness of individualised homeopathic treatment against fluoxetine (Prozac) and placebo. The methodology described is rigorous; randomised, double blind and double dummy. However, difficulties with recruitment resulted in only 11 participants being recruited to the study, 4 in the treatment group with only 5 patients completing the study (personal communication).
Davidson and colleagues reported homeopathic treatment of 12 patients with a range of diagnoses related to depression and anxiety disorders. 21 Full psychiatric diagnostic assessment together with a comprehensive homeopathic interview took place followed by individualised prescribing of the homeopathic treatment. 7 (58%) of patients were reported to have responded to homeopathic treatment, on the basis of the Clinical Global Improvement (CGI) scale, including 2 of the 3 patients with major depression. Type and potency of the remedies, duration of treatment and co-interventions varied between patients, as did the initial diagnoses leading to difficulties in interpreting the results.
However, this study was considered relevant to practice and valuable as a preliminary report by a clinical commentator involved in the current review.
There are several studies of the effects of homeopathy on mood or depression scores (among other outcomes), in patients with conditions such as cancer and chronic fatigue syndrome.
A 1 year randomised controlled trial of the treatment of 64 patients with post viral fatigue syndrome or ME (myalgic encephalomyelitis), included self-assessed mood disturbance as an outcome measure and found greater improvement in the syndrome overall with patients treated with individualised homeopathy compared with those in the placebo group. 18, 19 However, no other measures of mood or depression were taken and the significance of these results for patients with other conditions is unclear. For this reason, further details of this study are not included in the table of studies.
The studies in cancer patients are all uncontrolled and involve the use of homeopathy to treat a range of problems. Depression was only one of the problems reported and measured. These studies provide only relatively weak evidence of effectiveness, as lack of a control group and reporting of a range of outcomes leads to difficulties in interpretation of the results, particularly when assessing the extent to which any response is due to treatment with homeopathy. However, the findings are relevant to practice and therefore will be described here.
Clover and colleagues reported a series of 50 cancer patients in whom response to homeopathy treatment had been assessed using the Hospital Anxiety and Depression Scale (HADS) and Rotterdam Symptom Checklist. 20 Improvements were seen on the psychological distress subscale of the latter when comparing scores on initial and later (3 rd and 4 th ) visits and the percentage with normal HADS anxiety scores increased from 48% to 75% over this period However, the lack a control group, variable co-interventions and loss to follow-up of 58% lead to difficulties in interpretation of these findings.
More recently, in a well-designed uncontrolled clinical trial of the use of individualised homeopathy for symptom relief in 100 cancer patients, 52% of patients were found to have some improvement in depression scores at the end of the study period. 23 Up to 3 symptoms perceived by the patient as problematic were rated on a self-rating scale. Mood disturbance was assessed using the Hospital Anxiety and Depression Scale (HADS). At the beginning of the study, 37 patients were depressed with 20 having a diagnosis of depression (scores above 10) and 17 borderline depression (scores 8-10). There was a significant improvement in the mean depression score for the whole study group, comparing the baseline score with either the average over all visits or just the last visit (p<0.05). Overall, 52% of patients were found to have some improvement in depression scores at the end of the study period (4-6 consultations later), with a mean improvement of 1.4 (95% CI 0.1-2.6). Attrition rate was high; only 52% completed the study and 17 patients suffered an aggravation of symptoms or return of old symptoms considered to be previously described remedy reactions. No adverse reactions resulted in withdrawal of treatment. Satisfaction with treatment was measured by self-completion questionnaire and was high amongst those who completed the study; 75% regarded homeopathic treatment as having been helpful or better.
In a further uncontrolled clinical trial of individualised homeopathy for symptoms of oestrogen withdrawal in 45 breast cancer patients, a significant improvement in depression score was found among women with depression, but not of the group overall. 24 Twenty-six of the patients had also been included in the 2002 study. 23 89% of patients completed this study and again satisfaction with treatment was high; 67%
regarded homeopathic treatment as having been helpful, very helpful or extremely helpful for their symptoms.
An observational survey-based study of homeopathic treatment in 269 women with gynaecological disorders, 38% of whom were assessed as having mood disorders has been reported . 25 However, no information is given on diagnosis, the information was extracted from standardised questionnaires completed by 31 gynaecologists and the 269 questionnaires returned represented a response rate of only 28.5%. Response to treatment was based on physician and patient assessment rated on a 5-point scale and for 67% of women in the study (calculated on an intention-to-treat basis) a 'very good' or 'good' improvement in their mood disorder symptoms was recorded.
Finally, outcome studies including those of Clover 35 , Richardson 36 
Implications for the future
If shown to be effective, homeopathy might be a useful therapeutic option in depression; potential benefits over existing treatments include high patient acceptability, lack of adverse effects and safety in overdose. However the evidence base is currently weak.
The main problem in RCTs of homeopathy for depression has been recruitment. In principle it is possible to overcome this problem by using a very large recruitment base.
However, this would be inefficient and the low recruitment ratio such a design implies means that the recruited subjects would likely be atypical.
Further research is required, and should include well-designed controlled studies with sufficient numbers of participants. However, before launching such studies, development of methodologies and strategies to overcome recruitment problems is necessary. Patient preference, and the attitudes of health professionals appear to be important constraints to recruitment. Qualitative studies aimed at identifying and understanding patients' and health professionals' perceptions and attitudes should precede further RCTs.
Methodological options include the incorporation of preference arms or uncontrolled observational studies although both are less rigorous than RCTs. 41 , when well-designed, such studies give results similar to those of randomised controlled studies. 42 The highly individualised nature of much homeopathic treatment and the claimed specificity of response justifies innovative methods of analysis of individual response to treatment.
For instance in 'participant-centred analysis', subjects are declared benefited, nonresponder or harmed, on the basis of a predefined decision rule. Variables associated with these responses can then be analysed. 43 Finally, a substantial number of case studies were located. These provide an indication of the range of remedies employed in patients whose symptoms include depression.
However, conclusions about the effectiveness of homeopathic treatment cannot be drawn from these because of factors such as preferential reporting of successful or unusual cases, and regression to the mean. Such reports however might provide useful qualitative data concerning homeopathic treatment strategies, but synthesis of information from individual case reports is complex and impeded by a lack of structure and absent information in many reports. Efforts to encourage the publishing of high-quality structured case reports 44 , or consecutive case series of may help to address these problems. Methods aimed at utilising or synthesising data held with individual case studies either as a potential form of evidence or at least, as an illustration of how homeopathy is used in individuals with depression, may prove a valuable and rewarding approach in the future. 
Summary of studies
See separate file
